Today, a Director at Biomerica Inc (NASDAQ: BMRA), Allen Barbieri, bought shares of BMRA for $18.75K.
Following this transaction Allen Barbieri’s holding in the company was increased by 18.48% to a total of $463.2K. Following Allen Barbieri’s last BMRA Buy transaction on January 06, 2017, the stock climbed by 0.5%.
See today’s analyst top recommended stocks >>
Currently, Biomerica Inc has an average volume of 39.28K.
Starting in January 2018, BMRA received 4 Buy ratings in a row.
The insider sentiment on Biomerica Inc has been positive according to 10 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. It focuses on gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests.
